• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国老年人血浆五聚体蛋白3水平与慢性肾脏病风险的关系:东古研究

Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.

作者信息

Lee Ran, Shin Min-Ho, Kim Hee-Nam, Lee Young-Hoon, Choi Seong-Woo, Ahn Hye-Ran, Kweon Sun-Seog

机构信息

Department of Preventive Medicine, Chonnam National University Medical School, 160 Baekseo-ro, Dong-gu, Gwangju, 501-746, Korea.

Center for Creative Biomedical Scientists, Chonnam National University, 160 Baekseo-ro, Dong-gu, Gwangju, Korea.

出版信息

Int Urol Nephrol. 2017 Nov;49(11):2027-2033. doi: 10.1007/s11255-017-1662-3. Epub 2017 Jul 21.

DOI:10.1007/s11255-017-1662-3
PMID:28733767
Abstract

UNLABELLED

Purpose This study investigated the cross-sectional association between chronic kidney disease (CKD) and plasma pentraxin 3 (PTX3) levels in a Korean population, in a community-based cohort study.

METHODS

A total of 1816 (891 men, 925 women) subjects were randomly selected from the cohort of participants for the final analyses. Plasma PTX3 concentration was determined using enzyme-linked immunosorbent assays. The participants were divided into four quartiles according to the PTX3 levels. Multivariate logistic regression was performed to evaluate the association between plasma PTX3 level and CKD. Covariates inserted into the multivariate model included smoking status, systolic blood pressure, body mass index, waist circumference, high-density lipoprotein, low-density lipoprotein uric acid, white blood cell count, and carotid intima-media thickness.

RESULTS

Compared to the lowest PTX3 group (Q1), a significantly higher risk of CKD was found in the highest group (Q4), with an odds ratio of 1.58 and 95% confidence interval of 1.18-2.11 (P for trend <0.001).

CONCLUSIONS

This study showed that higher plasma PTX3 levels are significantly associated with CKD risk. The biological mechanism remains unclear; therefore, further molecular investigation of association between CKD and PTX3 is needed.

摘要

未标注

目的 在一项基于社区队列研究中,调查韩国人群中慢性肾脏病(CKD)与血浆五聚素3(PTX3)水平之间的横断面关联。

方法

从参与者队列中随机选取共1816名受试者(891名男性,925名女性)进行最终分析。采用酶联免疫吸附测定法测定血浆PTX3浓度。根据PTX3水平将参与者分为四个四分位数组。进行多因素逻辑回归以评估血浆PTX3水平与CKD之间的关联。纳入多因素模型的协变量包括吸烟状况、收缩压、体重指数、腰围、高密度脂蛋白、低密度脂蛋白、尿酸、白细胞计数和颈动脉内膜中层厚度。

结果

与PTX3最低组(Q1)相比,最高组(Q4)的CKD风险显著更高,优势比为1.58,95%置信区间为1.18 - 2.11(趋势P值<0.001)。

结论

本研究表明,较高的血浆PTX3水平与CKD风险显著相关。生物学机制尚不清楚;因此,需要对CKD与PTX3之间的关联进行进一步的分子研究。

相似文献

1
Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.韩国老年人血浆五聚体蛋白3水平与慢性肾脏病风险的关系:东古研究
Int Urol Nephrol. 2017 Nov;49(11):2027-2033. doi: 10.1007/s11255-017-1662-3. Epub 2017 Jul 21.
2
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.老年人群中 pentraxin 3 水平与慢性肾脏病发病率之间的关联。
J Intern Med. 2016 Feb;279(2):173-9. doi: 10.1111/joim.12411. Epub 2015 Sep 9.
3
Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study.无降脂药物治疗史人群中血浆 pentraxin-3 水平与血脂水平及心血管危险因素的关系:东固研究。
J Atheroscler Thromb. 2019 Aug 1;26(8):738-745. doi: 10.5551/jat.47167. Epub 2019 Jan 23.
4
Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.载脂蛋白 3 与肾功能障碍相关性的种族差异:动脉粥样硬化的多民族研究。
Nephrol Dial Transplant. 2011 Jun;26(6):1903-8. doi: 10.1093/ndt/gfq648. Epub 2010 Nov 15.
5
Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population.人群中 pentraxin 3(PTX3)血浆水平与颈动脉内膜中层厚度进展的关系。
Nutr Metab Cardiovasc Dis. 2014 May;24(5):518-23. doi: 10.1016/j.numecd.2013.10.030. Epub 2013 Dec 4.
6
Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: a case-control study.慢性肾脏病的危险因素可能包括牙周病,这可以通过血浆五聚素 3 水平的相关性来估计:一项病例对照研究。
Int Urol Nephrol. 2012 Jun;44(3):829-39. doi: 10.1007/s11255-011-9997-7. Epub 2011 Jun 3.
7
Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.在非肥胖类风湿关节炎患者中,血清五聚体蛋白3水平与颈动脉内膜中层厚度呈负相关。
Int J Cardiol. 2016 Oct 15;221:298-301. doi: 10.1016/j.ijcard.2016.06.175. Epub 2016 Jul 6.
8
Association between Plasma Pentraxin 3 Levels and Bone Mineral Density in Elderly Koreans: the Dong-gu Study.血浆 pentraxin 3 水平与老年韩国人骨密度的关系:东固研究。
J Korean Med Sci. 2018 May 9;33(23):e165. doi: 10.3346/jkms.2018.33.e165. eCollection 2018 Jun 4.
9
Plasma pentraxin 3 levels are associated with carotid IMT in type 1 diabetic patients.血浆 pentraxin 3 水平与 1 型糖尿病患者颈动脉 IMT 相关。
Diabetes Res Clin Pract. 2013 Feb;99(2):185-91. doi: 10.1016/j.diabres.2012.11.020. Epub 2012 Dec 13.
10
Serum Pentraxin 3 is associated with signs of arterial alteration in women with preeclampsia.血清五聚体蛋白3与先兆子痫女性的动脉改变迹象相关。
Int J Cardiol. 2017 Aug 15;241:417-422. doi: 10.1016/j.ijcard.2017.03.076. Epub 2017 Mar 24.

引用本文的文献

1
New Potential Biomarkers for Chronic Kidney Disease Management-A Review of the Literature.慢性肾脏病管理的新潜在生物标志物——文献综述。
Int J Mol Sci. 2020 Dec 22;22(1):43. doi: 10.3390/ijms22010043.
2
Aerobic Training Down-Regulates Pentraxin 3 and Pentraxin 3/Toll-Like Receptor 4 Ratio, Irrespective of Oxidative Stress Response, in Elderly Subjects.有氧运动训练可下调老年受试者的五聚素3以及五聚素3/ Toll样受体4比值,且与氧化应激反应无关。
Antioxidants (Basel). 2020 Jan 27;9(2):110. doi: 10.3390/antiox9020110.

本文引用的文献

1
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
2
Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.五聚体蛋白3在急性心肌梗死患者中的长期预后意义:一项5年前瞻性队列研究。
Anatol J Cardiol. 2017 Mar;17(3):202-209. doi: 10.14744/AnatolJCardiol.2016.7307. Epub 2016 Aug 2.
3
Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study.
肾脏疾病指标与特定病因死亡率的关联:韩国心脏研究
PLoS One. 2016 Apr 19;11(4):e0153429. doi: 10.1371/journal.pone.0153429. eCollection 2016.
4
How to improve duration and efficiency of the antiproteinuric response to Ramipril: RamiPROT-a prospective cohort study.如何提高对雷米普利抗蛋白尿反应的持续时间和效率:RamiPROT一项前瞻性队列研究
J Nephrol. 2017 Feb;30(1):95-102. doi: 10.1007/s40620-015-0256-3. Epub 2015 Dec 26.
5
Plasma Pentraxin3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease.血浆五聚体3水平与冠状动脉疾病患者经光学相干断层扫描评估的斑块易损性相关。
Int Heart J. 2016;57(1):18-24. doi: 10.1536/ihj.15-248. Epub 2015 Dec 17.
6
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.老年人群中 pentraxin 3 水平与慢性肾脏病发病率之间的关联。
J Intern Med. 2016 Feb;279(2):173-9. doi: 10.1111/joim.12411. Epub 2015 Sep 9.
7
[Is it feasible to improve the duration and the efficiency of Ramipril anti-proteinuric response?].提高雷米普利抗蛋白尿反应的持续时间和效率是否可行?
G Ital Nefrol. 2015 Jan-Feb;32(1).
8
Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation.五聚素-3 通过促进 M2 巨噬细胞分化来减轻糖尿病肾病的肾损伤。
Inflammation. 2015 Oct;38(5):1739-47. doi: 10.1007/s10753-015-0151-z.
9
Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.在尿毒症中 pentraxin 3 的循环水平升高和组织表达:反映内皮功能障碍。
PLoS One. 2013 May 3;8(5):e63493. doi: 10.1371/journal.pone.0063493. Print 2013.
10
Association of bone mineral density with albuminuria and estimated glomerular filtration rate: the Dong-gu Study.骨密度与蛋白尿和肾小球滤过率估计值的相关性:东固研究。
Kidney Blood Press Res. 2013;37(2-3):132-41. doi: 10.1159/000350067. Epub 2013 Apr 24.